breakingview - bristol-myer take $74 bln bet against the market
new york (reuter breakingview) - bristol-myer squibb is take a $74 billion bet against the market. there ar good reason to bui rival oncolog giant celgen. but cost cut don’t cover the 54 percent premium, and the target’s owner get the financi benefit. bristol is hope for luck in the court and multipl regulatori approv that celgen’s sharehold were skeptic of.
